[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100431874":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":63,"collaborators":66,"id":70,"slug":10,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":10,"maxAge":78,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Sydney Children's Hospitals Network","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Children and adolescents with newly diagnosed malignancy",null,[12],"Diagnostic Test: Family-based whole genome sequencing",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DIAGNOSTIC_TEST","Family-based whole genome sequencing","1. Germline whole-genome family-based sequencing and variant identification.\n2. Multidisciplinary Meeting case discussion.\n3. Recommendation of referral to a Cancer Genetics Clinic for further investigation, follow up and\u002For genetic counselling.\n4. Psychosocial study to analyse the impact of germline sequencing on families.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Clinical Trials Manager","CONTACT","+61 2 9382 3122","SCHN-PREDICT@health.nsw.gov.au",[26,42,54],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"John Hunter Children's Hospital","RECRUITING","Newcastle","New South Wales","2305","Australia",{"type":34,"coordinates":35},"Point",[36,37],151.7801,-32.92953,{"lat":37,"lon":36},[40],{"name":41,"role":22,"phone":10,"phoneExt":10,"email":10},"Frank Alvaro",{"facility":43,"status":28,"city":44,"state":30,"zip":45,"country":32,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"Sydney Children's Hospital","Sydney","2031",{"type":34,"coordinates":47},[48,49],151.20732,-33.86785,{"lat":49,"lon":48},[52],{"name":53,"role":22,"phone":10,"phoneExt":10,"email":10},"Kathy Tucker",{"facility":55,"status":28,"city":44,"state":30,"zip":56,"country":32,"cosmosGeoPoint":57,"geoPoint":59,"contacts":60},"The Children's Hospital at Westmead","2145",{"type":34,"coordinates":58},[48,49],{"lat":49,"lon":48},[61],{"name":62,"role":22,"phone":10,"phoneExt":10,"email":10},"Luciano Dalla-Pozza",{"type":64,"investigatorFullName":53,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Professor",[67],{"name":68,"class":69},"Children's Cancer Institute Australia","UNKNOWN","100431874",false,"NCT04903782","Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer","Assessment of the Utility of Family-based (Trio) Whole-genome Sequencing for Cancer Predisposition Testing in Sequential Newly Diagnosed Paediatric and Adolescent Cancer Patients","PREDICT","* New diagnosis of malignancy\n* Age ≤ 21 years\n* Written informed consent\n\nPsychosocial component:\n\n* Participants (≥ 12 years)\n* Parent\u002Fcaregiver(s) of participants\n* Healthcare professionals involved in the care of patients enrolled in the study","ALL","21 Years",{"count":80,"type":81},270,"ESTIMATED","OBSERVATIONAL","Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients",[85,86,87],"Neoplastic Syndromes, Hereditary","Cancer","Genetic Predisposition to Disease",[89,90,91,92,93,94,95],"Germ-line Mutation","Disease Susceptibility","Child","Pediatrics","Genomics","Next Generation Sequencing","Risk","2022-11-02",{"date":98,"type":99},"2022-11-04","ACTUAL",{"date":101,"type":99},"2021-03-08",{"date":103,"type":81},"2028-06-15",{"name":5,"class":6},3]